Cefazolin for Injection, USP, 1 gm vial

  • Potential Presence of Penicillin G Potassium Injection Vial
  • Company: Sandoz Inc.
  • Drugs
  • FDA
  • June 27, 2025

Product details

  • Cefazolin for Injection, USP, 1 gm vial

Company announcement

Sandoz Inc. is recalling one lot of Cefazolin for Injection, USP, 1 gram per vial, nationwide due to mispackaging.

Some cartons contained Penicillin G Potassium for Injection vials instead of Cefazolin.

The recall was initiated after a customer complaint.

Risk:

There is a reasonable probability that the inadvertent administration of penicillin G potassium injection, instead of intended cefazolin injection, may pose serious and potentially life-threatening adverse health consequences, including lack of efficacy leading to less than optimal treatment of severe infections, antibiotic resistance, adverse reactions, severe allergic reactions (e.g., anaphylaxis), drug interactions, cardiac arrhythmias resulting from high potassium especially in patients with kidney impairment, and delayed recovery.

Impacted states: Nationwide

Products:

- Cefazolin for Injection, USP, 1 gram per vial

- Penicillin G Potassium for Injection, USP

Contact

For more information, call 844-491-7872 or email Sandoz6004@sedgwick.com.

View the original FDA notice

Browse all recalls

Related recalls